Literature DB >> 16611882

An alternative splice product of IkappaB kinase (IKKgamma), IKKgamma-delta, differentially mediates cytokine and human T-cell leukemia virus type 1 tax-induced NF-kappaB activation.

Tao Hai1, Man-Lung Yeung, Thomas G Wood, Yuanfen Wei, Shoji Yamaoka, Zoran Gatalica, Kuan-Teh Jeang, Allan R Brasier.   

Abstract

NF-kappaB is an inducible transcription factor mediating innate immune responses whose activity is controlled by the multiprotein IkappaB kinase (IKK) "signalsome". The core IKK consists of two catalytic serine kinases, IKKalpha and IKKbeta, and a noncatalytic subunit, IKKgamma. IKKgamma is required for IKK activity by mediating kinase oligomerization and serving to couple the core catalytic subunits to upstream mitogen-activated protein 3-kinase cascades. We have discovered an alternatively spliced IKKgamma mRNA isoform, encoding an in-frame deletion of exon 5, termed IKKgamma-delta. Using a specific reverse transcription-PCR assay, we find that IKKgamma-delta is widely expressed in cultured human cells and normal human tissues. Because IKKgamma-Delta protein is lacking a critical coiled-coil domain important in protein-protein interactions, we sought to determine its signaling properties by examining its ability to self associate, couple to activators of the canonical pathway, and mediate human T-cell leukemia virus type 1 (HTLV-1) Tax-induced NF-kappaB activity. Coimmunoprecipitation and confocal colocalization assays indicate IKKgamma-delta has strong homo- and heterotypic association with wild-type (WT) IKKgamma and, like IKKgamma WT, associates with the IKKbeta kinase. Similarly, IKKgamma-delta mediates IKK kinase activity and downstream NF-kappaB-dependent transcription in response to tumor necrosis factor (TNF) and the NF-kappaB-inducing kinase-IKKalpha signaling pathway. Surprisingly, however, in contrast to IKKgamma WT, IKKgamma-delta is not able to mediate HTLV-1 Tax-induced NF-kappaB-dependent transcription, even though IKKgamma-delta binds and colocalizes with Tax. These observations suggest that IKKgamma-delta is a functionally distinct alternatively spliced mRNA product differentially mediating TNF-induced, but not Tax-induced, signals converging on the IKK signalsome. Differing levels of IKKgamma-delta expression, therefore, may affect signal transduction cascades coupling to IKK.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611882      PMCID: PMC1472011          DOI: 10.1128/JVI.80.9.4227-4241.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

Review 1.  The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.

Authors:  A A Beg; A S Baldwin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

2.  Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes.

Authors:  M R Smith; W C Greene
Journal:  Genes Dev       Date:  1990-11       Impact factor: 11.361

3.  A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.

Authors:  Kai-Li He; Adrian T Ting
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

4.  Nuclear role of I kappa B Kinase-gamma/NF-kappa B essential modulator (IKK gamma/NEMO) in NF-kappa B-dependent gene expression.

Authors:  Udit N Verma; Yumi Yamamoto; Shashi Prajapati; Richard B Gaynor
Journal:  J Biol Chem       Date:  2003-11-03       Impact factor: 5.157

5.  Segregation of NF-kappaB activation through NEMO/IKKgamma by Tax and TNFalpha: implications for stimulus-specific interruption of oncogenic signaling.

Authors:  Hidekatsu Iha; Karen V Kibler; Venkat R K Yedavalli; Jean-Marie Peloponese; Kerstin Haller; Akiko Miyazato; Takefumi Kasai; Kuan-Teh Jeang
Journal:  Oncogene       Date:  2003-12-04       Impact factor: 9.867

6.  A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha.

Authors:  Eric D Tang; Cun-Yu Wang; Yue Xiong; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

7.  Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases.

Authors:  Alain Chariot; Antonio Leonardi; Jurgen Muller; Marianne Bonif; Keith Brown; Ulrich Siebenlist
Journal:  J Biol Chem       Date:  2002-07-19       Impact factor: 5.157

8.  Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.

Authors:  K L Guan; J E Dixon
Journal:  Anal Biochem       Date:  1991-02-01       Impact factor: 3.365

9.  The human DNA polymerase beta gene structure. Evidence of alternative splicing in gene expression.

Authors:  Y J Chyan; S Ackerman; N S Shepherd; O W McBride; S G Widen; S H Wilson; T G Wood
Journal:  Nucleic Acids Res       Date:  1994-07-25       Impact factor: 16.971

Review 10.  Identification of a nuclear factor kappa B-dependent gene network.

Authors:  Bing Tian; Allan R Brasier
Journal:  Recent Prog Horm Res       Date:  2003
View more
  10 in total

Review 1.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

2.  Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.

Authors:  Ping Liu; Mohammad Jamaluddin; Kui Li; Roberto P Garofalo; Antonella Casola; Allan R Brasier
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

Review 3.  Alternative splicing in the NF-kappaB signaling pathway.

Authors:  Joshua R Leeman; Thomas D Gilmore
Journal:  Gene       Date:  2008-07-22       Impact factor: 3.688

Review 4.  Expanding role of cyclin dependent kinases in cytokine inducible gene expression.

Authors:  Allan R Brasier
Journal:  Cell Cycle       Date:  2008-09-12       Impact factor: 4.534

Review 5.  The role of the IKK complex in viral infections.

Authors:  Moushimi Amaya; Forrest Keck; Charles Bailey; Aarthi Narayanan
Journal:  Pathog Dis       Date:  2014-08-28       Impact factor: 3.166

6.  Transcription Independent Stimulation of Telomerase Enzymatic Activity by HTLV-I Tax Through Stimulation of IKK.

Authors:  M Bellon; Y Yuan; C Nicot
Journal:  J Cancer Sci       Date:  2021-09-05

7.  Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype.

Authors:  Younglang Lee; Alex W Wessel; Jiazhi Xu; Julia G Reinke; Eries Lee; Somin M Kim; Amy P Hsu; Jevgenia Zilberman-Rudenko; Sha Cao; Clinton Enos; Stephen R Brooks; Zuoming Deng; Bin Lin; Adriana A de Jesus; Daniel N Hupalo; Daniela Gp Piotto; Maria T Terreri; Victoria R Dimitriades; Clifton L Dalgard; Steven M Holland; Raphaela Goldbach-Mansky; Richard M Siegel; Eric P Hanson
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 14.808

8.  Expression of an IKKgamma splice variant determines IRF3 and canonical NF-kappaB pathway utilization in ssRNA virus infection.

Authors:  Ping Liu; Muping Lu; Bing Tian; Kui Li; Roberto P Garofalo; Deborah Prusak; Thomas G Wood; Allan R Brasier
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240

9.  The role of IKKβ in Venezuelan equine encephalitis virus infection.

Authors:  Moushimi Amaya; Kelsey Voss; Gavin Sampey; Svetlana Senina; Cynthia de la Fuente; Claudius Mueller; Valerie Calvert; Kylene Kehn-Hall; Calvin Carpenter; Fatah Kashanchi; Charles Bailey; Soren Mogelsvang; Emanuel Petricoin; Aarthi Narayanan
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

Review 10.  Interactions of Alphavirus nsP3 Protein with Host Proteins.

Authors:  Tyler Lark; Forrest Keck; Aarthi Narayanan
Journal:  Front Microbiol       Date:  2018-01-09       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.